AstraZeneca sells stake in Moderna for $1.2bn
1st Mar 2021 08:41
(Sharecast News) - AstraZeneca has cashed in on its bet on Moderna, it was revealed on Monday, as the latter's share price rocketed on the success of its Covid-19 vaccine.
Read moreAstraZeneca and Pfizer vaccines cut hospitalisations significantly
22nd Feb 2021 12:32
(Sharecast News) - The UK's vaccination programme is having "spectacular" success in reducing the number of serious illnesses, the results of a study showed.
Read moreAstraZeneca withdraws Imfinzi US indication for advanced bladder cancer
22nd Feb 2021 08:04
(Sharecast News) - Drugmaker AstraZeneca announced the voluntary withdrawal of its Imfinzi indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer on Monday.
Read moreJohnson to push G-7 on measures to speed development of new vaccines
19th Feb 2021 13:57
(Sharecast News) - The Prime Minister will push his G7 country counterparts on Friday to cut the development time needed for vaccines against new Covid-19 strains from 300 days to 100.
Read moreAstraZeneca's breast cancer drug moves to early primary analysis
17th Feb 2021 07:52
(Sharecast News) - AstraZeneca said the phase 3 trial for breast cancer drug Lynparza would move to early primary analysis and reporting following a recommendation from the Independent Data Monitoring Committee (IDMC).
Read moreUK officials concerned by continued mutations in Covid-19 strains
11th Feb 2021 12:40
(Sharecast News) - A top UK health official expressed concern about the likely spread of the so-called UK variant worldwide and the fact that it was continuing to mutate.
Read moreAfrica to continue with AstraZeneca vaccination program
11th Feb 2021 10:51
(Sharecast News) - The African Union's disease control body said on Thursday that it would continue using the AstraZeneca Covid19 vaccine, after trial data showed it had greatly reduced efficacy against the coronavirus variant dominant in South Africa.
Read moreThursday preview: US jobless claims, AstraZeneca in the spotlight
10th Feb 2021 18:52
(Sharecast News) - The economic calendar on Thursday will be exceedingly light with a reading on weekly US unemployment claims the only event that might easily move markets.
Read moreAstraZeneca to invest in new Covid-19 vaccine production in Eastern Germany
10th Feb 2021 16:03
(Sharecast News) - AstraZeneca may partner with Germany's IDT Biologika to produce its Covid-19 vaccine in a bid to bolster supplies.
Read moreWednesday broker round-up
10th Feb 2021 13:12
(Sharecast News) - Ocado Group: Berenberg reiterates buy with a target price of 2,925p.
Read moreWHO claims animals 'most likely' origin of SARS-CoV-2
9th Feb 2021 11:55
(Sharecast News) - World Health Organization scientists who have been studying the origin of the Covid-19 virus in China over the past four weeks concluded that the most likely origin of the illness was in animals.
Read more'Jury still out' on whether world needs new Covid-19 vaccines, Oxford's Pollard says
9th Feb 2021 09:29
(Sharecast News) - It remains to be seen whether the world needs new vaccines to fend off the new strains of novel coronavirus, a top researcher said.
Read moreAstraZeneca vaccine protects against severe Covid-19 from SA variant, ShoreCap says
9th Feb 2021 09:15
(Sharecast News) - The novel coronavirus vaccine developed by AstraZeneca and the University of Oxford is likely effective in preventing severe cases of Covid-19, or those requiring hospitalisation, analysts at Shore Capital said.
Read moreSouth Africa halts AstraZeneca vaccinations after weak results against local variant
8th Feb 2021 12:34
(Sharecast News) - South Africa halted its rollout of AstraZeneca's Covid-19 vaccine after a study claimed that it offered "minimal protection" against mild to moderate disease from the local variant of the novel coronavirus.
Read moreSunday newspaper round-up: AstraZeneca, Amazon, Retailers
7th Feb 2021 11:55
(Sharecast News) - Vaccines Minister Nadhim Zahawi today said AstraZeneca is 'confident' its jab prevents serious illness caused by the South African coronavirus variant after early data from a small study suggested the vaccine was less effective against the strain. Mr Zahawi said he had spoken to England's Deputy Chief Medical Officer Jonathan Van Tam this morning about the study as he insisted the vaccine 'does protect against severe disease'. He said that through its own trials AstraZeneca is 'confident that it does effectively deal with serious illness, serious disease and hospitalisation'. - Financial Mail on Sunday
Read more